Sep 14, 2023

New OICR investigator combines physics, chemistry, and artificial intelligence to improve tissue imaging

Aug 29, 2023

The Next Generation: Jingping Qiao

Jul 27, 2023

The Next Generation: Tom Ouellette

Jun 20, 2023

New funding partnership with U of T Data Sciences Institute aims to drive new breakthroughs

Sep 27, 2022

The Next Generation: Mahmoud Noureldin

Sep 03, 2020

Analyzing SARS-CoV-2: A cancer researcher trainee’s perspective

Mar 02, 2020

Study reveals roots of leukemia that current chemotherapies can’t reach

Feb 27, 2020

Innovative drug screening method finds new promising molecules to treat aggressive lung cancers

Jan 10, 2020

New open-source software judges accuracy of algorithms that predict tumour evolution

Jul 09, 2018

New institute to make chronic disease prevention across Canada BETTER

Jun 19, 2018

More than 300,000 Canadians enrol in multi-decade research initiative to monitor disease trends

Jun 13, 2018

Viral protein identified as one of the main drivers of virus-induced stomach cancers

Mar 29, 2018

Canada’s largest health research platform teams up with University of Toronto to accelerate cancer and chronic disease research

Dec 07, 2017

Finding new ways to prevent virus-induced stomach cancers

Dec 04, 2017

OICR launches groundbreaking Cancer Therapeutics Innovation Pipeline to drive cutting-edge therapies to the clinic

Oct 23, 2017

Boost your bioinformatics knowledge at TorBUG

May 18, 2016

OICR congratulates J. Mark Lievonen and Laurence Klotz on their investiture in the Order of Canada

May 17, 2016

Dr. Eva Grunfeld named as Chair of new Canadian Institute of Health Research Institutes Advisory Board on Chronic Conditions

May 11, 2016

Recruiting the next generation

May 01, 2016

Dr. Gang Zheng named to AIMBE College of Fellows for nanotechnology research

May 01, 2016

OICR invests in early-stage Ontario oncology drug development

Apr 29, 2016

Technology developed with OICR funding receives $4 million in support from NCI

Jan 07, 2016

Ontario Institute for Cancer Research invests $1.2 million to support oncology drug development in Ontario